
NYSE:IBM
This summary was created by AI, based on 25 opinions in the last 12 months.
IBM Common Stock has received mixed reviews from various experts, showcasing a blend of confidence and caution regarding its future. The stock has experienced a significant drop, down 17% this year, yet many analysts see potential growth driven by key sectors like AI and quantum computing. While various analysts recognize the company's considerable investments in hybrid cloud and AI, concerns about its valuation and past performance also emerge. Analysts generally agree that despite some execution slip-ups, IBM maintains strong software capabilities and a promising future, particularly with its $1.3 trillion addressable market in quantum computing by 2030. Overall, while some view IBM as a buying opportunity, others express worries about its competitive position and valuation metrics.
Sold some AVGO to buy this recently. It trades at under 3x sales. Free cash flow has grown in the last 6 quarters from $7 billion to $12 billion, which he loves. Wants to see the 3% dividend grow. They get AI exposure through Red hat and Watson X. Shares have done nothing for 3-5 years, but the last quarter was excellent. It's old-school tech, but more conservative than AI stocks and is dividend-focused. It's not the old IBM. Very optimistic.
Price target raised, though it's below the current share price. As we move into cloud, big data and AI, the big winners are in data like IBM. IBM is old and sleepy, but they bought Red Hat and will be a winner in this space, though not flashy but rather slow and steady. Pays a nearly 4% as you wait.
Open architecture through Red Hat, highly appealing. Long shot, but a possibility, that it'll be able to develop an open architecture to make it competitive in AI. If yes, it's going much higher. Getting act together, getting rid of legacy divisions. Don't go wild, but he wouldn't argue strenuously against adding it as part of a well-balanced portfolio.
It's finally breathing some life into its stock. The 4.1% dividend is one factor, and falling interest rates will help. Their Q1 and Q2 saw sales lighter than expected, though posted big earnings beat. However, they beat revenues and earnings last month, plus strong cash flow. The CEO has been touting hybrid AI to clients. Their key AI platform is Watson X, launched last spring. Their consulting business makes up a third of revenues but is overlooked. Shares trades at only 16x PE 2024. 43% of sales are from software, and 33% from consulting. This is consistent. IBM its recent upgrades.
IBM lacks the spread of clientele like MSFT. Also, IBM has been getting rid of their hardware business, focusing more on software with AI. In terms of quality, MSFT is better (customer loyalty, Office Suite) while IBM is inferior, offering little growth. IBM isn't a big player moving forward. Among megatech, MSFT is the top.
Legacy name that's trying to adapt. Now much more about services and subscriptions. Getting into AI through Watson, which long ago beat a world-class chess player and won a bunch of money on Jeopardy! Partnered with META and OpenAI. 18x earnings, not expensive. Good yield of 3.37%.
(Analysts’ price target is $183.38)